학술논문
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies
Document Type
Artikel
Author
Source
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 52(2):244-249
Subject
Language
English
English
English
ISSN
1365-2222